Diabetes and Heart Failure: Pathogenesis and Novel Therapeutic Approaches
Sardu, Celestino
Diabetes and Heart Failure: Pathogenesis and Novel Therapeutic Approaches - Frontiers Media SA 2019 - 1 electronic resource (122 p.)
Open Access
This eBook is a collection of articles from a Frontiers Research Topic. Frontiers Research Topics are very popular trademarks of the Frontiers Journals Series: they are collections of at least ten articles, all centered on a particular subject. With their unique mix of varied contributions from Original Research to Review Articles, Frontiers Research Topics unify the most influential researchers, the latest key findings and historical advances in a hot research area! Find out more on how to host your own Frontiers Research Topic or contribute to one as an author by contacting the Frontiers Editorial Office: frontiersin.org/about/contact
Creative Commons
English
978-2-88945-851-6 9782889458516
10.3389/978-2-88945-851-6 doi
Science: general issues
Physiology
diabetes Heart Failure diastolic dysfunction arrhythmia SGLT2 (sodium-glucose cotransporter 2) inhibitor GLP-1 - glucagon-like peptide-1
Diabetes and Heart Failure: Pathogenesis and Novel Therapeutic Approaches - Frontiers Media SA 2019 - 1 electronic resource (122 p.)
Open Access
This eBook is a collection of articles from a Frontiers Research Topic. Frontiers Research Topics are very popular trademarks of the Frontiers Journals Series: they are collections of at least ten articles, all centered on a particular subject. With their unique mix of varied contributions from Original Research to Review Articles, Frontiers Research Topics unify the most influential researchers, the latest key findings and historical advances in a hot research area! Find out more on how to host your own Frontiers Research Topic or contribute to one as an author by contacting the Frontiers Editorial Office: frontiersin.org/about/contact
Creative Commons
English
978-2-88945-851-6 9782889458516
10.3389/978-2-88945-851-6 doi
Science: general issues
Physiology
diabetes Heart Failure diastolic dysfunction arrhythmia SGLT2 (sodium-glucose cotransporter 2) inhibitor GLP-1 - glucagon-like peptide-1
